Compass Therapeutics Inc. logo

Compass Therapeutics Inc.

CMPX | NASDAQ
Chart Builder DCF Calculator
$1.82
-$0.08 (-4.21%)
At close: Sep 21, 2026, 4:00 PM ET
$1.07
-$0.75 (-41.21%)
Pre-market: Sep 22, 2026, 8:44 AM ET

Market Data

Market Cap
$327.76M
Enterprise Value
$157.51M
Beta
0.85
Average Volume
7.58M
Shares Outstanding (Diluted)
186.8M
Shares Change YoY
35.08%
Institutional Ownership
92.94%
Exchange
NASDAQ
ISIN
US20454B1044

Price Performance

Price Change 1M
-24.5%
Price Change 3M
-11.7%
Price Change 6M
-66.8%
Price Change YTD
-64.8%
Price Change 1Y
-47.9%
Price Change 3Y
-7.1%
Price Change 5Y
-48.0%
1M CAGR (ann.)
-15.3%
1Y CAGR (ann.)
-50.5%
5Y CAGR (ann.)
-12.3%
All-Time CAGR
-24.6%

Valuation

PE Ratio
-4.44
Forward PE
N/A
PEG Ratio
-0.50
Forward PEG
-0.42
PS Ratio
N/A
Forward PS
14.10
PB Ratio
1.97
P/FCF Ratio
-5.95
P/Adj. FCF Ratio
-4.82
P/OCF Ratio
-6.28
EV/Sales
N/A
EV/EBIT
-2.14
EV/EBITDA
-2.17
EV/FCF
-2.86
Earnings Yield
-22.5%
FCF Yield
-16.8%
Adj. FCF Yield
-20.8%

Financial Health

Net Cash
$170.25M
Total Debt
$9.63M
Cash & Short-Term Investments
$179.88M
Total Assets
$190.17M
Current Ratio
11.22
Quick Ratio
11.22
Debt / Equity Ratio
0.06
Debt / EBITDA
-0.13
Debt / FCF
-0.18
OCF / Debt
-5.69
Interest Coverage
0.00
Altman Z-Score
4.42
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-23.5%

Returns

Return on Assets
-38.6%
Return on Equity
-38.7%
Return on Invested Capital
-46.1%
Return on Capital Employed
-46.6%
Return on Tangible Assets
-38.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
-150.0%
Revenue CAGR 5Y
0.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-6.2%
EPS CAGR 5Y
1.9%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-12.7%
FCF CAGR 5Y
-16.0%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
16
EPS Growth Next 3Y
52.9%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.12
EPS Growth Est (next Q)
50.0%
Revenue Est (next Q)
$229.25K
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$6
Price Target Upside
229.7%

Cash Flow

Operating Cash Flow
$-54.79M
Free Cash Flow
$-55.05M
Adj. Free Cash Flow
$-68.01M
FCF Per Share
-$0.29
OCF Per Share
-$0.29
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-738K
Operating Income
$-81.09M
EBITDA
$-72.67M
Net Income
$-73.45M
EPS (Diluted)
-$0.41
Revenue / Employee
N/A
Profit / Employee
$-1.88M
Employees
39

© 2026 bestshares.com. All rights reserved.